Greater Cleveland
Accomplished sales leader with award-winning recognition for increasing company revenue and exceeding sales targets by leveraging outstanding pharmaceutical and clinical science knowledge, cementing client relationships, and demonstrating expertise in organizational development and performance management and, in other words, creatively growing sales through territory development. Talent for identifying limitations and implementing initiatives that increase the team’s confidence, sales skills, and company profitability. Distinguished for propelling territory sales by ~ $44 M in six years Oncology Product Experience: Alimta (pemetrexed): Mesothelioma, NSCLC Erbitux (cetuximab): CRC, head and neck cancer Gemzar (gemcitabine): Pancreatic cancer, NSCLC, ovarian cancer, breast cancer Opdivo (nivolumab): Metastatic melanoma, NSCLC, renal cell carcinoma, head, and neck cancer Yervoy (ipilimumab): Metastatic melanoma and renal cell carcinoma Rybrevant (amivantamab): EGFR-mutated NSCLC Lazcluze (lazertinib): EGFR-mutated NSCLC
Grew sales over 93% in the first year in the territory AND Launch year, from <$1M to > $15.7M. Launched Rybrevant (Amivantamab) and Lazcluze (Lazertinib) in THREE EGFR-mutated NSCLC indications in the Cleveland area, including the Cleveland Clinic and University Hospitals of Cleveland. Delivered multiple data review presentations to districts and region. Recognized as a data content expert by leadership. • Grew sales to 136% over quota for 2025 • District Representative of the Year 2025 • President’s Circle 2025. #7 rank of 94.
Promoted to Executive Territory Business Manager in just two years. Serve as a nationally recognized expert in a hybrid sales, marketing, and data analysis position. Provided 40 presentations to staff virtually, in consideration of COVID restrictions. Provide key input as a product specialist to the Field Input Team. Offer direction to the Lung Marketing Team in preparation for BMS’s first-line lung cancer IO combination. Nominated to serve on the National Opdivo Lung Consultant Team yearly for five years. Launched Opdivo (Nivolumab) to a 94% market share, ranking number four of 84 in the nation. Finished number one for Opdivo sales in 2019 and placed fourth through eighth for six previous years, attaining Winner’s Circle recognition. Catapulted territory sales from $3.2M to $44.3M over six years. Boosted Yervoy sales 94% in 2014. Voted as Mid-Atlantic STAR five times within two years in recognition of excellence. Founded The Coley Evidence League, a national immuno-oncology science group to enhance the team’s knowledge and increase confidence in selling immuno-oncology products.
Devised a highly successful territory plan to address a sales environment with no new data and limited corporate support. Promoted and advanced sales of Alimta and Gemzar cytotoxic chemotherapy and Erbitux monoclonal antibody to oncologists and medical professionals at the Cleveland Clinic Foundation and other cancer centers. Became the sole specialist in the district to exceed quota; realized 127% QTD by 2014. Advanced Altimta sales to $2.2M in two years, surpassing quota seven of eight years. Recognized as District Programming Champion; implemented a company-wide programming plan that placed the district among the top two.
• Achieved top ranking selling diabetic pharmaceutical products, earning Top 20 accolades and the District Peer Award in 2000, 2001 and 2002 • Actively played a role in prototype development of the Humalog Mix Pen for a national marketing campaign • Designated by specialty physician clients as the #1 Specialist in the territory • Installed software and trained clinicians in its use at Humalog CSII study sites in Tampa and Dallas • Built top-tier sales teams, acting as a trusted guide and mentor for new hires
• Negotiated sales agreements with hospital accounts; influenced decisions of physicians, directors of pharmacy, VA medical center staff and nurses • Achieved company's #1 sales ranking nationally • Sold FasPak IV System to 10 accounts compared to national average of one per territory • Established first sales ever of Humatrope, growth hormone, at the Cleveland Clinic Foundation